The anti-CTLA-4 antibody, Ipilimumab, also known as YERVOY, was FDA approved for the treatment of metastatic melanoma in 2011. Ipilimumab works by inhibiting CTLA-4, a protein on T-cells that prevents them from attacking cancer cells. Only about 10-20% of melanoma patients respond to Ipilimumab. Sin.....
[更多]
Due toincreasing safety issues with liquid based electrolytes, there has been a greatinterest in the field of solid-state lithium batteries with a solvent freeelectrolyte. The invention involves novel block copolymer electrolytes withtapered interfaces between copolymer blocks. Block copolymers are .....
[更多]
| |< <- | [6530] [6531] [6532] [6533] [6534] [6535] [6536] [6537] [6538] [6539] [6540] | -> >| |
